Showing results 9 to 10 of 10
< previous
| Title | Author(s) | Issue Date | |
|---|---|---|---|
The central melanocortin system as a treatment target for obesity and diabetes: A brief overview Journal:European Journal of Pharmacology | 2022 | ||
α-Melanocyte-stimulating hormone reduces severity of retinal damage after retinal ischemia/reperfusion injury in type I diabetes Proceeding/Conference:Investigative Ophthalmology & Visual Science | 2022 |